Matches in Wikidata for { <http://www.wikidata.org/entity/Q34492429> ?p ?o ?g. }
- Q34492429 description "2015 nî lūn-bûn" @default.
- Q34492429 description "2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած" @default.
- Q34492429 description "2015 թվականի օգոստոսին հրատարակված գիտական հոդված" @default.
- Q34492429 description "2015年の論文" @default.
- Q34492429 description "2015年論文" @default.
- Q34492429 description "2015年論文" @default.
- Q34492429 description "2015年論文" @default.
- Q34492429 description "2015年論文" @default.
- Q34492429 description "2015年論文" @default.
- Q34492429 description "2015年论文" @default.
- Q34492429 description "2015年论文" @default.
- Q34492429 description "2015年论文" @default.
- Q34492429 description "2015年论文" @default.
- Q34492429 description "2015年论文" @default.
- Q34492429 description "2015年论文" @default.
- Q34492429 description "2015년 논문" @default.
- Q34492429 description "article científic" @default.
- Q34492429 description "article scientific" @default.
- Q34492429 description "article scientifique (publié 2015)" @default.
- Q34492429 description "articol științific" @default.
- Q34492429 description "articolo scientifico" @default.
- Q34492429 description "artigo científico (publicado na 2015)" @default.
- Q34492429 description "artigo científico (publicado na 2015)" @default.
- Q34492429 description "artigo científico" @default.
- Q34492429 description "artikull shkencor" @default.
- Q34492429 description "artikulong pang-agham" @default.
- Q34492429 description "artykuł naukowy" @default.
- Q34492429 description "artículo científico publicado en 2015" @default.
- Q34492429 description "artículu científicu espublizáu en 2015" @default.
- Q34492429 description "bilimsel makale" @default.
- Q34492429 description "bài báo khoa học" @default.
- Q34492429 description "mokslinis straipsnis" @default.
- Q34492429 description "naučni članak" @default.
- Q34492429 description "scienca artikolo" @default.
- Q34492429 description "scientific article" @default.
- Q34492429 description "teaduslik artikkel" @default.
- Q34492429 description "tieteellinen artikkeli" @default.
- Q34492429 description "tudományos cikk" @default.
- Q34492429 description "vedecký článok" @default.
- Q34492429 description "vetenskaplig artikel" @default.
- Q34492429 description "videnskabelig artikel (udgivet 2015)" @default.
- Q34492429 description "vitenskapelig artikkel" @default.
- Q34492429 description "vitskapeleg artikkel" @default.
- Q34492429 description "vědecký článek" @default.
- Q34492429 description "wetenschappelijk artikel" @default.
- Q34492429 description "wissenschaftlicher Artikel" @default.
- Q34492429 description "επιστημονικό άρθρο" @default.
- Q34492429 description "мақолаи илмӣ" @default.
- Q34492429 description "мақолаи илмӣ" @default.
- Q34492429 description "наукова стаття, опублікована в серпні 2015" @default.
- Q34492429 description "научна статия" @default.
- Q34492429 description "научная статья" @default.
- Q34492429 description "научни чланак" @default.
- Q34492429 description "научни чланак" @default.
- Q34492429 description "מאמר מדעי" @default.
- Q34492429 description "سائنسی مضمون" @default.
- Q34492429 description "مقالة علمية" @default.
- Q34492429 description "مقالهٔ علمی" @default.
- Q34492429 description "২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q34492429 description "บทความทางวิทยาศาสตร์" @default.
- Q34492429 description "სამეცნიერო სტატია" @default.
- Q34492429 name "FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study." @default.
- Q34492429 name "FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study." @default.
- Q34492429 name "FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study." @default.
- Q34492429 type Item @default.
- Q34492429 label "FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study." @default.
- Q34492429 label "FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study." @default.
- Q34492429 label "FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study." @default.
- Q34492429 prefLabel "FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study." @default.
- Q34492429 prefLabel "FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study." @default.
- Q34492429 prefLabel "FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study." @default.
- Q34492429 P1433 Q34492429-3437D702-1A9E-45E7-ADCE-82D5C8260546 @default.
- Q34492429 P1476 Q34492429-8D49355E-8E1C-4A3D-9AC8-A4175F364D40 @default.
- Q34492429 P2093 Q34492429-0047C0C6-E805-430B-A217-7F8DD84563C5 @default.
- Q34492429 P2093 Q34492429-4D4F11DD-1CBD-456F-A110-ED756CB6BE4E @default.
- Q34492429 P2093 Q34492429-99355BBC-DAEC-447B-8CF9-B123A02D9614 @default.
- Q34492429 P2093 Q34492429-9B203519-A1EF-421A-9BEC-891207050142 @default.
- Q34492429 P2093 Q34492429-9E0C97F9-B91B-4567-BF73-16A9543474F4 @default.
- Q34492429 P2093 Q34492429-C3BF9936-DF5C-4C0B-87EC-FCECE6F9C6B1 @default.
- Q34492429 P2093 Q34492429-C3C1AE9B-B61F-4FC2-A39D-441D8CC0DF38 @default.
- Q34492429 P2093 Q34492429-C77D54CB-E3BD-4FF2-BDEA-5A83F1EE4F86 @default.
- Q34492429 P2093 Q34492429-DA0F28F3-29CB-456A-BFC7-E5B7700FE2E8 @default.
- Q34492429 P2093 Q34492429-ECA66CA7-0497-42BB-82F4-92CC809CD4A7 @default.
- Q34492429 P2093 Q34492429-ED09440A-1047-456B-8486-09522FFCB09E @default.
- Q34492429 P2860 Q34492429-091A382A-9C53-42A9-9EF5-10449640D161 @default.
- Q34492429 P2860 Q34492429-096C9106-0CA7-40A4-81DB-676AF13479DE @default.
- Q34492429 P2860 Q34492429-0F507D59-4D19-445D-9154-EA06D20A2780 @default.
- Q34492429 P2860 Q34492429-1F53508C-916D-4DB7-AD3A-A79E6D0335C7 @default.
- Q34492429 P2860 Q34492429-21EBAA21-F76A-4A9E-A815-6F1E551C9F65 @default.
- Q34492429 P2860 Q34492429-51BE399C-BA45-4CC3-8555-9321324AAC8B @default.
- Q34492429 P2860 Q34492429-6044EC2F-E6ED-4516-B24F-BB2A09EA52FF @default.
- Q34492429 P2860 Q34492429-606007F8-736E-45A3-8CFA-28268ABF6535 @default.
- Q34492429 P2860 Q34492429-6406A0D7-09C6-4538-B71E-CC3FF8205AFA @default.
- Q34492429 P2860 Q34492429-78B914C7-EBD5-4C27-9822-F2922D40F593 @default.
- Q34492429 P2860 Q34492429-7B80B12A-7CF1-411A-B727-38AC807BB179 @default.
- Q34492429 P2860 Q34492429-8CEAC866-CFD5-4B8D-85BE-E1AAA848E1C1 @default.
- Q34492429 P2860 Q34492429-8FA5CADB-4FEC-4E35-AB3D-6DE1F6AD05AB @default.
- Q34492429 P2860 Q34492429-953CEC31-5C44-4146-9186-7DA2ADDBE31A @default.
- Q34492429 P2860 Q34492429-A970725D-9B59-45CA-AC9F-6CFEF5C9360E @default.
- Q34492429 P2860 Q34492429-B040BD60-3359-4563-B772-5553512D4034 @default.